- Apple had a breakthrough on a revolutionary blood glucose monitor, according to Bloomberg.
- The project began under Steve Jobs, and has been underway for more than a decade.
Apple reportedly had a breakthrough on a secret project that could launch the company into a major force in the healthcare industry, Bloomberg $4 Wednesday.
It's a monitor that can $4 without as much as a skin prick, $4 to Bloomberg. Instead, Apple's monitor will use optical absorption spectroscopy, a measurement process that relies on wavelengths of light to ultimately determine glucose levels, Bloomberg $4.
The secret endeavor — called E5 — has been under wraps for the past several years, $4 to Bloomberg.
The project is part of the company's Exploratory Design Group, XDG, which is reportedly one of the most undercover initiatives at the company, Bloomberg $4. There are reportedly fewer people involved with E5 than there are with the company's self-driving car endeavor or its mixed reality headset, Bloomberg $4.
Before E5 was incorporated into XDG, it was reportedly operating under a startup called Avolonte Health LLC, Bloomberg $4.
Avolonte was reportedly headquartered in Palo Alto, California — close to Apple's own headquarters in Cupertino — and team members had Avolonte badges instead of Apple badges, Bloomberg $4. It was a way for Apple to keep its cover as it ran the project through human trials, amassed patients, and made partnerships, Bloomberg $4.
$4. When it does, the company will be positioned to disrupt a multimillion dollar industry where approximately 1 in 10 Americans $4, and prick their skin to monitor their glucose levels, Bloomberg $4.
Apple did not immediately respond to Insider's request for a comment.